Chicago Capital’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.8M Buy
241,803
+39,557
+20% +$6.59M 0.89% 36
2026
Q1
$42.4M Buy
202,246
+20,015
+11% +$5.03M 1.14% 31
2025
Q4
$51.8M Buy
182,231
+2,625
+1% +$821K 1.28% 29
2025
Q3
$55.4M Buy
179,606
+1,610
+0.9% +$504K 1.36% 28
2025
Q2
$55.9M Buy
177,996
+6,702
+4% +$1.93M 1.38% 28
2025
Q1
$45M Buy
171,294
+2,516
+1% +$681K 1.27% 31
2024
Q4
$44.1M Buy
168,778
+344
+0.2% +$86.6K 1.17% 30
2024
Q3
$39.2M Buy
168,434
+5,557
+3% +$1.14M 1.09% 35
2024
Q2
$32.9M Sell
162,877
-4,361
-3% -$786K 0.98% 38
2024
Q1
$28.7M Buy
167,238
+61,628
+58% +$11.5M 0.87% 38
2023
Q4
$22.9M Buy
105,610
+24,747
+31% +$4.24M 0.83% 37
2023
Q3
$12.9M Buy
+80,863
New +$18.1M 0.6% 42

Other funds holding PODD

Chicago Capital's PODD Position: Q2 2026 in Review

Chicago Capital increased its Insulet (PODD) stake by 20% in Q2 2026, buying an estimated $6.59M and bringing the position to 241,803 shares worth $36.8M. The position accounts for 0.89% of the portfolio, ranked #36.

Chicago Capital first reported a position in PODD in Q3 2023 and has held it in 12 quarters since. The position peaked at $55.9M in Q2 2025. 228 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Chicago Capital held 241,803 shares of Insulet worth $36.8M as of Q2 2026.
  • Chicago Capital bought 39,557 Insulet shares in Q2 2026, an estimated $6.59M.
  • Insulet made up 0.89% of Chicago Capital's portfolio in Q2 2026, its #36 holding.
  • Chicago Capital first reported a position in Insulet in Q3 2023 and has held it in 12 quarters since.
  • Chicago Capital's Insulet position peaked at $55.9M in Q2 2025.
  • 228 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.